NCT01294969View on ClinicalTrials.gov

Patient Perception Study for AL-4943A

PHASE4CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Allergic Conjunctivitis
Interventions
DRUG

AL-4943A

Once daily topical ocular allergy medication used for 7 days

Trial Locations (1)

06181

Alcon Korea Ltd., Seoul

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY